Health officials warned on Monday that COVID-19 infections in Canada have surged and that if people do not take strict precautions, they may rise to levels above the levels during the first wave of the pandemic.
The Department of Public Health said in a statement: “Canada is at a crossroads, and individual actions to reduce contact rates will determine our path.”
According to the worst-case scenario outlined by the agency, by October 2nd, the number of daily cases may increase by more than 1,000 to 155,795, and the death toll will reach 9,300. On Monday, Canada reported 145,415 total cases and 9,228 deaths.
Prime Minister Justin Trudeau will appear on a rare evening national broadcast at 6:30 pm (2230 GMT) on Wednesday to talk about “Fighting COVID-19 as we deny the prospect of the second wave of the virus Urgency”. The Prime Minister’s Office said.
Dr. Lisa Tan, Chief Public Health Officer of Canada, outlined three scenarios for the spread of the new coronavirus from now to January 2022. The most favorable scenario is a slight increase now and then “slow burning” next year.
This result requires active case detection and tracking, as well as individuals who take necessary health precautions. However, if no action is taken, the consequences can be catastrophic.
She said: “With minimal control, the virus can soar to a very sharp and strong peak… (probably) overwhelming our health system and having a significant impact on our social and economic system.”
Tam said that even with enhanced detection and tracking capabilities, people must take precautions, otherwise the situation may “far” exceed the spring peak.
Tam is the latest in a series of warnings issued by Canadian health officials that the spread of the disease is accelerating.
Tan said this increase is different from the initial increase because young people are not within the scope of transmission, but she warns that eventually “this will spread to high-risk groups.”
Purchasing Minister Anita Anand also announced a new agreement to purchase the final coronavirus vaccine for Canada and purchased 150,000 vials of remidivir, an antiviral drug produced by Gilead Sciences. Gil.
Anand said that Canada has signed agreements with Sanofi and GlaxoSmithKline. GlaxoSmithKline Up to 72 million doses of the potential adjuvant COVID-19 vaccine can be produced, and the previous agreement with Moderna has added 14 million doses Ribonucleic acid Candidate vaccine.
In addition, the governor of Ontario, Canada’s largest province, Doug Ford (Doug Ford) said that he will begin to implement a six-point plan “to deal with the second batch of COVID-19 that may be more challenging.”
The first step is what Ford calls the “largest flu vaccination campaign” in Ontario’s history. The province invested 70 million Canadian dollars ($52.6 million) in 5.1 million influenza vaccines, an increase of 700,000 from last year.
Ford said that during the coronavirus surge, influenza vaccination will help “reduce the burden and burden on hospitals and doctors’ offices.”
Reporting by Steve Scherer, additional reporting by David Ljunggren; Editing by Steve Orlofsky and David Gregorio